Options
Adjuvant Trastuzumab for 6 Months is Effective in Patients with HER2-positive Stage II or III Breast Cancer
Type
article
Resource
Tai CJ, Pan CK, Chen CS, Hung CS, Wu CH, Chiou HY(2013).Adjuvant Trastuzumab for 6 Months is Effective in Patients with HER2-positive Stage II or III Breast Cancer. Asian Pac J Cancer Prev.(14):1981-1984.
Date Issued
2013
Author(s)
CJ, Tai;CK, Pan;CS, Chen;CS, Hung;CH, Wu;HY, Chiou
Subjects
公共衛生學系
期刊論文